Valuation : Alkem Laboratories Limited

Market Cap 62TCr 659.43Cr 568.89Cr 535.91Cr 488.28Cr 912.67Cr 919.51Cr 6.34TCr 2.46TCr 32TCr 2.48TCr 2.42TCr 1,04600Cr P/E 2027 *
27.1x
P/E 2028 * 23.6x
Enterprise Value 61TCr 645.59Cr 556.95Cr 524.65Cr 478.02Cr 893.5Cr 900.2Cr 6.21TCr 2.41TCr 31TCr 2.42TCr 2.37TCr 1,02400Cr EV / Sales 2027 *
3.65x
EV / Sales 2028 * 3.2x
Free-Float
37.56%
Yield 2027 *
0.95%
Yield 2028 * 1.06%
1 day-1.70%
1 week-2.56%
Current month-2.68%
1 month-9.44%
3 months-2.01%
6 months-7.60%
Current year-5.36%
1 week 5,199.8
Extreme 5199.8
5,400
1 month 5,173.5
Extreme 5173.5
5,771
Current year 5,085
Extreme 5085
5,933
1 year 5,085
Extreme 5085
5,933
3 years 3,440.05
Extreme 3440.05
6,440
5 years 2,835
Extreme 2835
6,440
10 years 1,400
Extreme 1400
6,440
Manager TitleAgeSince
President - -
President - -
Director of Finance/CFO - 01/02/2024
Director TitleAgeSince
Director/Board Member 44 09/08/2013
Director/Board Member 63 11/02/2008
Director/Board Member 45 11/11/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.70%-2.56% - - 667.71Cr
+0.01%-2.47%+57.79%+107.83% 1,03400Cr
+1.48%+1.93%+54.56%+71.28% 65TCr
+0.67%-0.45%+23.50%+79.14% 46TCr
+0.49%-6.58%+34.20%+34.59% 34TCr
+0.27%+2.32%+29.33%+46.97% 31TCr
+0.12%-4.01%+1.06%+11.93% 25TCr
+1.08%+0.57%+54.34%+74.34% 24TCr
+2.64%-2.00%-17.38%-53.64% 20TCr
-0.21%+1.03%+32.74%+99.06% 19TCr
Average +0.51%-2.88%+30.02%+52.39% 40.8TCr
Weighted average by Cap. +0.66%-3.31%+38.85%+67.79%

Financials

2027 *2028 *
Net sales 17TCr 176.78Cr 152.51Cr 143.67Cr 130.9Cr 244.67Cr 246.5Cr 1.7TCr 660.1Cr 8.54TCr 663.83Cr 649.32Cr 28TCr 19TCr 196.6Cr 169.61Cr 159.78Cr 145.57Cr 272.1Cr 274.14Cr 1.89TCr 734.11Cr 9.5TCr 738.26Cr 722.12Cr 31TCr
Net income 2.31TCr 24Cr 21Cr 20Cr 18Cr 34Cr 34Cr 235.71Cr 91Cr 1.18TCr 92Cr 90Cr 3.89TCr 2.72TCr 29Cr 25Cr 23Cr 21Cr 40Cr 40Cr 276.56Cr 107.33Cr 1.39TCr 107.94Cr 105.58Cr 4.56TCr
Net Debt -1.31TCr -14Cr -12Cr -11Cr -10Cr -19Cr -19Cr -133.22Cr -52Cr -668.71Cr -52Cr -51Cr -2.2TCr -2.81TCr -30Cr -26Cr -24Cr -22Cr -41Cr -41Cr -285.78Cr -110.91Cr -1.43TCr -111.54Cr -109.1Cr -4.71TCr
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
02/26/02 5,210.00 -1.70% 1,938
01/26/01 ₹5,300.00 -1.00% 1,201
31/26/31 ₹5,353.40 +0.06% 958
28/26/28 ₹5,350.15 +0.67% 1,251
27/26/27 ₹5,314.35 -0.48% 1,924
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,210.00INR
Average target price
5,948.55INR
Spread / Average Target
+14.18%

Quarterly revenue - Rate of surprise